The Russian government has approved a plan to develop new… (россия · лекарство · препарат)
The Russian government has approved a plan to develop new pharmaceuticals and medical technologies by 2030, including personalized treatments, tissue engineering products, and radiopharmaceuticals, with key agencies responsible for implementation and annual reporting. Prime Minister Mikhail Mishustin emphasized the need for breakthrough innovations in medicine, particularly in oncology, and stressed that domestically developed drugs must be both accessible and comparable to foreign counterparts.
Consensus
- The Russian government has approved a plan to develop new pharmaceuticals and medical technologies by 2030.
- New drugs and medical methods should include personalized treatments, tissue engineering products, biomedicine cell-based products, and radiopharmaceuticals.
- Ministry of Health, Ministry of Science and Higher Education, Roszdravnadzor, FMBA, and Ministry of Industry and Trade are responsible for implementing the plan.
- Annual reports on progress will be submitted to the government starting next year.
- The goal is to achieve technological leadership in healthcare within Russia.
Points of divergence
- New drugs must be introduced into practice annually. — riamo
- Prime Minister Mikhail Mishustin emphasized that new medical products should be accessible to citizens and comparable in quality to foreign equivalents. — kommersant
- Rostec has delivered 102,000 units of medical equipment and over 90 million consumables for neonatology, cardiology, gynecology, etc., in the past year. — kommersant
- Rostec completed testing of a mobile device for non-invasive therapy of breast and thyroid tumors called 'Meduza'. — kommersant
- A company-developed oncological scanner that reduces diagnosis time to minutes has been registered, and Rostec is preparing it for mass production. — kommersant
Coverage (2 sources)
- By 2030 Russia will develop new drugs and treatment methods — РИАМО
- Mishustin: Russia has opportunities to create fundamentally new medicines — Коммерсантъ